Detection of doping control sample substitutions via single nucleotide polymorphism‐based ID typing
Drug Testing and Analysis · 2023
DOI: 10.1002/dta.3597 ↗At a glance
Journal article in Drug Testing and Analysis, 2023. Written by Nana Naumann and 5 co-authors. Institution: Center for Preventive Doping Research, Institute of Biochemistry, German Sport University Cologne, Cologne, Germany. Major MEDLINE topics: Doping in Sports, Sports. Cited 8 times so far (Crossref); 39 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Bundesministerium des Innern, für Bau und Heimat.
Abstract (original language)
The authenticity of a doping control sample is a key element of sports drug testing programmes. Doping control sample manipulation by providing another individual's urine or blood (instead of the tested athlete's sample) has been observed in the past and is an unequivocal violation of the World Anti‐Doping Agency anti‐doping rules. To determine attempts of manipulations by sample swapping, the utility of a single nucleotide polymorphism (SNP)‐based sample authentication with a multi‐target SNP panel was assessed. The panel comprises detection assays for 44 different SNPs, 3 gender markers and 5 quality control markers for DNA‐profile determination. Sample analysis is based on a multiplex polymerase chain reaction step followed by a multiplex single base extension (SBE) reaction and subsequent SBE‐product detection by MALDI‐TOF MS. Panel performance was evaluated for urine and dried blood spot (DBS) samples. Urine (8 ml) and DBS (20 μl) test samples were reliably typed and matched to whole blood reference samples, while efficient typing of urine samples correlated with sample quality and input amounts. Robust profiling of urine doping control specimens was confirmed with an assay input of 12 ml. Samples can be processed in a high‐throughput format with an overall assay turnaround time of approximately 11 h. SNP‐based DNA typing via MALDI‐TOF MS thus represents a high throughput‐capable possibility for doping control sample authentication. SNP profiling of samples could offer the opportunity to complement existing steroid profile analytics to substantiate sample manipulations and to support quality control processes in high throughput routine settings.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Center for Preventive Doping Research, Institute of Biochemistry, German Sport University Cologne, Cologne, Germany.
- Laboratory Medicine, Hospital Universitario Son Espases, Palma, Spain.
ORCID profiles: Nana Naumann, Katja Walpurgis, Andreas Thomas, Mario Thevis
Funding
- Bundesministerium des Innern, für Bau und Heimat
Cite
APA
Naumann, N., Walpurgis, K., Rubio, A., Thomas, A., Paßreiter, A., & Thevis, M. (2023). Detection of doping control sample substitutions via single nucleotide polymorphism‐based ID typing. Drug Testing and Analysis. https://doi.org/10.1002/dta.3597
Vancouver
Naumann N, Walpurgis K, Rubio A, Thomas A, Paßreiter A, Thevis M. Detection of doping control sample substitutions via single nucleotide polymorphism‐based ID typing. Drug Testing and Analysis. 2023. doi:10.1002/dta.3597
BibTeX
@article{Naumann2023,
author = {Naumann, Nana and Walpurgis, Katja and Rubio, Ana and Thomas, Andreas and Paßreiter, Alina and Thevis, Mario},
title = {Detection of doping control sample substitutions via single nucleotide polymorphism‐based ID typing},
journal = {Drug Testing and Analysis},
year = {2023},
doi = {10.1002/dta.3597}
}
EUVIMED